| License: Creative Commons: Attribution 3.0 PDF - Published Version (486kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-351217
- DOI to cite this document:
- 10.5283/epub.35121
Abstract
Background: Patients undergoing liver transplantation with preexisting renal dysfunction are prone to further renal impairment with the early postoperative use of Calcineurin-inhibitors. However, there is only little scientific evidence for the safety and efficacy of de novo CNI free "bottom-up" regimens in patients with impaired renal function undergoing liver transplantation. This is a ...

Owner only: item control page